- KinBio is a rapidly growing biopharmacetucical company based in Rehovot, Israel, with its main focus on developing needed therapies as well as offering a wide range of CDMO services – from concept to product.
- KinBio’s main focus is to pursue opportunities in the global pharmaceutical market. Augmented by a global group of affiliated companies, Kinbio specializes in research, development, manufacturing and commercialization of biopharmaceutical products.
- Kinbio’s commitment to top standard quality is inherent across the entire global organization, from our FDA approved cGMP sites to our state of the art research and development laboratories in pursuit of life-changing and life-saving medications.
- Our success is driven by global reach that combines large fully fledged manufacturing capabilities with focused clinical and regulatory strategy, enhanced by a worldwide marketing network.
